{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.3"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"description":"Difference in measure of weight in kilograms of subject at baseline and at week 24 after continuing on study treatment for the entire 24 week period.","dispersionType":"Standard Deviation","groups":[{"description":"Patients receive oral cyproheptadine hydrochloride twice daily for up to 24 weeks in the absence of weight loss or unacceptable toxicity.","id":"OG000","title":"Arm I- Cyproheptadine Hydrochloride"},{"description":"Patients receive oral cyproheptadine hydrochloride twice daily and oral PediaSure (2 to 10 years of age) or Ensure (\\> 10 years of age) twice daily for up to 24 weeks in the absence of weight loss or unacceptable toxicity.","id":"OG001","title":"Arm II Cyproheptadine HCl and PediaSure or Ensure"}],"paramType":"MEAN","reportingStatus":"POSTED","timeFrame":"24 weeks","title":"Difference Between Measures of Weight at Baseline and at Week 24","type":"PRIMARY","unitOfMeasure":"kilograms"}